Breaking News

Ben Venue Extends Manufacturing Stoppage

Quality issues to derail sterile injectables till 4Q12

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Ben Venue Laboratories will extend the voluntary suspension of manufacturing at its Bedford, OH facility. The site is one of the largest sterile injectable facilities in the world, with aseptic filling, lyophilization and cytotoxic manufacturing in four factories. The suspension, originally announced on November 19, 2011, was prompted after an internal review indicated that routine preventive maintenance and requalification of some manufacturing equipment was overdue. Those issues were also not...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters